PERCEPTIVE ADVISORS LLC - 11 Nov 2025 Form 4 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Role
10%+ Owner
Signature
/s/ Joseph Edelman - for Perceptive Life Sciences Master Fund Ltd., By: Perceptive Advisors LLC, its investment manager, By: Joseph Edelman, its managing member
Issuer symbol
LYRA
Transactions as of
11 Nov 2025
Net transactions value
-$182,515
Form type
4
Filing time
13 Nov 2025, 17:07:48 UTC
Previous filing
10 Nov 2025
Next filing
23 Dec 2025

Reporting Owners (4)

Name Relationship Address Signature Signature date CIK
PERCEPTIVE ADVISORS LLC 10%+ Owner 51 ASTOR PLACE, 10TH FLOOR, NEW YORK /s/ Joseph Edelman - for Perceptive Life Sciences Master Fund Ltd., By: Perceptive Advisors LLC, its investment manager, By: Joseph Edelman, its managing member 13 Nov 2025 0001224962
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD 10%+ Owner 51 ASTOR PLACE, 10TH FLOOR, NEW YORK /s/ Joseph Edelman - for Perceptive LS (A), LLC, By: Perceptive LS GP, LLC, its General Partner, By: Joseph Edelman, its sole member 13 Nov 2025 0001249675
Perceptive LS (A), LLC 10%+ Owner 51 ASTOR PLACE, 10TH FLOOR, NEW YORK /s/ Joseph Edelman - for Perceptive Advisors LLC, By: Joseph Edelman, its managing member 13 Nov 2025 0001797811
EDELMAN JOSEPH 10%+ Owner 51 ASTOR PLACE, 10TH FLOOR, NEW YORK /s/ Joseph Edelman 13 Nov 2025 0001164426

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LYRA Common Stock Sale $20,637 -4,783 -2.9% $4.31 161,318 11 Nov 2025 See Footnotes F1, F2, F3
transaction LYRA Common Stock Sale $2,317 -537 -2.9% $4.31 18,122 11 Nov 2025 See Footnotes F1, F2, F4
transaction LYRA Common Stock Sale $31,915 -7,862 -4.9% $4.06 153,456 12 Nov 2025 See Footnotes F2, F3, F5
transaction LYRA Common Stock Sale $3,584 -883 -4.9% $4.06 17,239 12 Nov 2025 See Footnotes F2, F4, F5
transaction LYRA Common Stock Sale $111,531 -28,597 -19% $3.90 124,859 13 Nov 2025 See Footnotes F2, F3, F6
transaction LYRA Common Stock Sale $12,531 -3,213 -19% $3.90 14,026 13 Nov 2025 See Footnotes F2, F4, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

PERCEPTIVE ADVISORS LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.25 to $4.61 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.
F2 Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to Perceptive Life Sciences Master Fund, Ltd. (the "Master Fund"). Perceptive LS GP, LLC ("GP") is the manager of Perceptive LS (A), LLC ("Perceptive LS"). Joseph Edelman is the managing member of the Advisor and the sole member of GP. Each of Mr. Edelman, GP and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that Mr. Edelman, GP or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
F3 The securities reported in this row are held by the Master Fund.
F4 The securities reported in this row are held by Perceptive LS.
F5 The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.90 to $4.27 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.
F6 The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.90 to $3.91 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.